SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Crist DW,Sitzmann JV,Cameron JL. Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg. 1987; 206: 358365.
  • 2
    Winter JM,Cameron JL,Campbell KA, et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg. 2006; 10: 11991210; discussion 1210–1191.
  • 3
    Pawlik TM,Abdalla EK,Barnett CC, et al. Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer. Arch Surg. 2005; 140: 584589; discussion 589–591.
  • 4
    Sohn TA,Yeo CJ,Cameron JL, et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 2000; 4: 567579.
  • 5
    Pawlik TM,Gleisner AL,Cameron JL,Winter JM, et al. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery. 2007; 141: 610618.
  • 6
    Di Giorgio A,Alfieri S,Rotondi F, et al.Pancreatoduodenectomy for tumors of Vater's ampulla: report on 94 consecutive patients.World J Surg.2005;29:513518.
  • 7
    Beger HG,Treitschke F,Gansauge F,Harada N,Hiki N,Mattfeldt T. Tumor of the ampulla of Vater: experience with local or radical resection in 171 consecutively treated patients. Arch Surg. 1999; 134: 526532.
  • 8
    Qiao QL,Zhao YG,Ye ML, et al. Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection. World J Surg. 2007; 31: 137143; discussion 144–136.
  • 9
    Klapdor R,Seutter E,Lang-Polckow EM,Reichle H,Hinrichs A. Locoregional/systemic chemotherapy of locally advanced/metastasized pancreatic cancer with a combination of mitomycin-C and gemcitabine and simultaneous follow-up by imaging methods and tumor markers. Anticancer Res. 1999; 19: 24592469.
  • 10
    Lillemoe KD,Cameron JL,Yeo CJ, et al. Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer? Ann Surg. 1996; 223: 718725; discussion 725–718.
  • 11
    Weitz J,Blumgart LH,Fong Y, et al. Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma. Ann Surg. 2005; 241: 269276.
  • 12
    Yamada H,Katoh H,Kondo S,Okushiba S,Morikawa T. Hepatectomy for metastases from noncolorectal and nonneuroendocrine tumor. Anticancer Res. 2001; 21: 41594162.
  • 13
    Hemming AW,Sielaff TD,Gallinger S, et al. Hepatic resection of noncolorectal nonneuroendocrine metastases. Liver Transpl. 2000; 6: 97101.
  • 14
    Elias D,Cavalcanti de Albuquerque A,Eggenspieler P, et al. Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients. J Am Coll Surg. 1998; 187: 487493.
  • 15
    Adam R,Chiche L,Aloia T, et al. Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg. 2006; 244: 524535.
  • 16
    Strasberg SM, for the International Hepato-Pancreato-Biliary Association Terminology Committee Survey. The Brisbane 2000 terminology of liver anatomy and resections. HPB. 2000; 2: 333339.
  • 17
    Kaplan EL,Meier P. Nonparametric estimation from incomplete observations. Am Stat Assoc J. 1958; 53: 457480.
  • 18
    Laurent C,Rullier E,Feyler A,Masson B,Saric J. Resection of noncolorectal and nonneuroendocrine liver metastases: late metastases are the only chance of cure. World J Surg. 2001; 25: 15321536.
  • 19
    Harrison LE,Brennan MF,Newman E, et al. Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-6 patients. Surgery. 1997; 121: 625632.
  • 20
    Yedibela S,Gohl J,Graz V, et al. Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review. Ann Surg Oncol. 2005; 12: 778785.
  • 21
    Adam R,Aloia T,Krissat J, et al. Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg. 2006; 244: 897907; discussion 907–898.
  • 22
    Vlastos G,Smith DL,Singletary SE, et al. Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases. Ann Surg Oncol. 2004; 11: 869874.
  • 23
    Pawlik TM,Vauthey JN,Abdalla EK,Pollock RE,Ellis LM,Curley SA. Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver. Arch Surg. 2006; 141: 537543; discussion 543–534.
  • 24
    Pawlik TM,Zorzi D,Abdalla EK, et al. Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncol. 2006; 13: 712720.
  • 25
    Pawlik TM,Gleisner AL,Bauer TW, et al. Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis. Ann Surg Oncol. 2007; 14: 28072816.
  • 26
    Ozaki H,Kinoshita T,Kosuge T, et al. An aggressive therapeutic approach to carcinoma of the body and tail of the pancreas. Cancer. 1996; 77: 22402245.
  • 27
    Takada T,Yasuda H,Amano H,Yoshida M,Uchida T. Simultaneous hepatic resection with pancreato-duodenectomy for metastatic pancreatic head carcinoma: does it improve survival? Hepatogastroenterology. 1997; 44: 567573.
  • 28
    Shimada K,Kosuge T,Yamamoto J,Yamasaki S,Sakamoto M. Successful outcome after resection of pancreatic cancer with a solitary hepatic metastasis. Hepatogastroenterology. 2004; 51: 603605.
  • 29
    Howard JM. Pancreatoduodenectomy (Whipple resection) with resection of hepatic metastases for carcinoma of the exocrine pancreas. [Letter.] Arch Surg. 1997; 132: 1044.
  • 30
    Conlon KC,Dougherty E,Klimstra DS,Coit DG,Turnbull AD,Brennan MF. The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy. Ann Surg. 1996; 223: 134140.
  • 31
    Pietrabissa A,Caramella D,Candio GD, et al. Laparoscopy and laparoscopic ultrasonography for staging pancreatic cancer critical appraisal. World J Surg. 1999; 23: 9981002; discussion 1003.